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Abstract
Background: After E. coli O157, E. coli O26 is the second most prevalent enterohaemorrhagic E. coli (EHEC) serotype
identified in cases of foodborne illness in Australia and throughout the world. E. coli O26 associated foodborne
outbreaks have drawn attention to the survival capabilities of this organism in a range of environments. The aim of
the present study was to assess the ability of E. coli O26 to survive the effects of disinfectants, acids and
antimicrobials and investigate the possible influence of virulence genes in survival and persistence of E. coli O26
from human and cattle sources from Australia.
Results: Initial characterization indicated that E. coli O26 are a genetically diverse group that were shown to belong
to a number of pathotypes. Overall, 86.4% of isolates were susceptible to all antimicrobials tested with no
significant differences in resistance observed between pathotypes. A representative subset of isolates (n = 40) were
selected to determine their ability to survive disinfectants at proposed industry working concentrations and acid
stress. Profoam, Kwiksan 22, and Topactive DES. were able to inhibit the growth of 100% of isolates. The remaining
three disinfectants (Dairy Chlor 12.5%, Envirosan and Maxifoam) were not effective against the subset of 40 E. coli
O26. Finally, elevated MICs (1,024 to 4,096 μg/ml) of acetic, propionic, lactic, and citric acids were determined for
the majority of the isolates (85%).
Conclusions: Australian E. coli O26 isolates belong to a range of pathotypes that harbor differing virulence markers.
Despite this, their response to antimicrobials, disinfectants and acids is similar confirming that stress response
appears unrelated to the presence of EHEC virulence markers. Notwithstanding, the tolerance to disinfectants and
the elevated acid MICs for EHEC and the other E. coli O26 pathotypes examined in this study may contribute to
bacterial colonization on food contact surfaces and subsequent foodborne illness caused by this pathogen.
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Background
Enterohaemorrhagic Escherichia coli (EHEC) strains
have been associated with a number of food-borne out-
breaks which have led to life threatening sequelae such
as hemolytic uremic-syndrome (HUS) and hemolytic
colitis (HC) [1–3]. Epidemiological surveillance indicates
that E. coli of O157:H7 serotype is the most frequently
encountered EHEC implicated in sporadic and outbreak
cases of illness [4]. However, other non-O157 serotypes such
as O26:H11, O45:H2, O103:H2, O111:H8, O121:H19,
O145:H28 and their non-motile forms have emerged and are
now considered an important cause of human infection
resulting in HUS [5]. Among the non-O157 serotypes, E. coli
O26:H11 is one of the major serotypes of concern [3, 6].
Although it is not completely understood which suite
of bacterial virulence determinants are most necessary
for E. coli O26 to cause disease in humans, isolates re-
covered from human clinical samples typically possess
* Correspondence: salmaaibsais.lajhar@griffithuni.edu.au
1School of Natural Sciences, Griffith University, Brisbane, QLD, Australia
2CSIRO Agriculture and Food, Brisbane, QLD, Australia
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lajhar et al. BMC Microbiology  (2017) 17:47 
DOI 10.1186/s12866-017-0963-0
Shiga toxins 1 or 2 or both (stx1, stx2) encoded by
lambdoid bacteriophages, the E. coli attaching and effac-
ing gene (eae) which is located on the LEE island and is
necessary for bacterial colonisation of the gut and for-
mation of the A/E lesion, and enterohemolysin (ehx), a
plasmid encoded virulence factor thought to work syner-
gistically with stx and contribute to the pathogenicity of
EHEC [7–10]. It has been recognised that cattle repre-
sent a major reservoir of E. coli O26 [11–13]. Exposure
to this pathogen can occur by a variety of routes includ-
ing contact with animals on farms, consumption of con-
taminated meat, milk and its derivatives, water, spinach,
sliced watermelon, clover sprouts, blueberries and straw-
berries [11, 14–20]. The contamination of food products
with either stx positive or stx negative E. coli O26 strains
has been reported previously [21–25] and in some cases
it has resulted in the recall of food products and a num-
ber of outbreaks [6, 18, 26]. In 2005, there was an out-
break in France due to consumption of unpasteurised
cow cheese contaminated with EHEC O26 [27]. In 2007,
EHEC O26 infections occurred amongst consumers of
ice cream produced from pasteurised milk made and
sold at a farm in Belgium [23]. Additionally, multistate
outbreaks of EHEC O26 infections in the USA have been
also reported by the CDC in 2010, 2011, 2013 and 2015
[16, 17, 28].
The detection of E. coli O26 isolates in various envi-
ronments including food, processing equipment and
food contact surfaces and identifying them as a causative
agent for a number of food-borne outbreaks creates the
need for implementing prevention strategies to control
this pathogen. Food producers and processors can use a
range of antimicrobial agents such as sanitizers and dis-
infectants to assist in controlling this organism. Resist-
ance of E. coli strains recovered from various
environments to a variety of antimicrobial agents has
been reported [29–32]. Variations in the response of dif-
ferent strains of E. coli to a range of disinfectants was
demonstrated by Skaloud et al., [31] and Beier et al., [32]
and suggest that the stress response of a range of E. coli
strains may be highly variable. To date, most studies
have focused on the survival capability of E. coli
O157:H7 and minimal information is known about the
response of E. coli O26 strains to these types of
stressors. It cannot be assumed that E. coli O26 will re-
spond similarly to E. coli O157:H7 or other E. coli
strains when exposed to antimicrobial agents. We
hypothesised that EHEC O26 have enhanced ability to
persist and survive antimicrobial intervention in their
planktonic state and that this consequently contributes
to EHEC incidence and infection. Therefore, the aim of
the present study was to assess the ability of E. coli O26
recovered from human clinical cases and cattle sources
to resist the effects of disinfectants, acids and
antimicrobials in the planktonic state and investigate the
possible association of virulence genes such as stx and
eae with the survival of Australian E. coli O26 from
human and cattle sources.
Methods
Bacterial strains
A total of 88 E. coli O26 isolates collected previously
from human clinical (10) and cattle (78) sources between
1995 and 2013 were utilised in this study. E. coli O26
isolates were initially selected with broad criteria based
on virulence profiles, time and source. Isolates stored at
-80°C in protect bacterial preservers (Technical Service
Consultants Ltd) were subcultured on tryptone soya agar
(TSA; Oxoid, UK) and incubated at 37 °C overnight.
PCR
Whole cell suspensions were created by suspending a
single colony in 200 μl sterile Milli-Q water and tested
by PCR for the presence of stx (stx1 and stx2), eae, ehx,
eae conserved fragment (ecf ), and bundle forming pilus
(bfpA), using the primers shown in Table 1. PCR master
mix containing 10X Dream Taq™ Buffer (Thermo Fisher
Scientific, Australia), 250 mM dNTPs (Thermo Fisher
Scientific, Australia), 0.02 mg/ml bovine serum Albumin
(Sigma-Aldrich, USA), 12.5 pmol forward and reverse
primer (GeneWorks, Australia) and 1.25 U Taq DNA
polymerase (GeneWorks, Australia) was used. PCR
products were subjected to gel electrophoresis on 2%
agarose gels for 45 min at 100 V with resulting bands
then visualised using a UV transilluminator. The antici-
pated amplicon size for each PCR product is shown in
Table 1.
Detection of rmlA SNP using RFLP
A single nucleotide difference (G→T) at position 30
within rmlA has been shown to be associated with the
presence of stx in E. coli isolates [33]. Primers rmlA
30snp-F and rmlA 30snp-R were used to amplify a
484 bp portion of rmlA (Table 1). Amplified PCR prod-
ucts were digested for 4 h at 37 °C using the restriction
enzyme AciI. PCR products were subjected to gel elec-
trophoresis on 2% agarose gels for 45 min at 100 V with
resulting bands then visualised using a UV transillumi-
nator. Isolates harbouring the rmlA SNP yielded 10 bp
(not visible), 161 bp and 313 bp fragments whereas those
isolates without the SNP yielded 10 bp (not visible), 109,
161 and 204 bp fragments.
Antimicrobial Resistance (AMR)
To determine the AMR phenotype of E. coli O26 isolates
a custom susceptibility panel AUSVN2 (TREK Diagnos-
tics, UK) designed specifically for testing Australian
Gram-negative isolates was used. All plates were
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inoculated and assessed using the Sensititre system
(TREK Diagnostics). Antimicrobials that were tested are
cefazolin, cefotaxime, ceftiofur, amoxicillin / clavulanic
acid, nalidixic acid, cefoxitin, ciprofloxacin, meropenem,
ceftriaxone, gentamicin, ampicillin, trimethoprim / sulfa-
methoxazole, chloramphenicol, kanamycin, tetracycline
and streptomycin. The Clinical and Laboratory Stan-
dards Institute (CLSI) criteria were utilised to identify
antimicrobial resistance breakpoints when available;
otherwise European Committee on Antimicrobial
Susceptibility Testing (EUCAST) and National Anti-
microbial Resistance Monitoring System (NARMS)
values were used. E. coli ATCC 25922 was used as a
control strain.
Pulse-field gel electrophoresis (PFGE)
PFGE was performed using the standardised PulseNet
protocol with chromosomal DNA of Salmonella ser.
Braenderup H9812 digested with XbaI (Roche diagnos-
tics, USA) used as a molecular size marker [34, 35].
PFGE gels were analysed using BioNumerics V7.5
(Applied Maths, Belgium).
Disinfectant and acid susceptibility
A total of six disinfectants and four acids were evaluated
for their antimicrobial efficacy against E. coli O26 iso-
lates. The disinfectants and acids tested were Topactive
DES (Ecolab Pty Ltd, Australia), Dairy Chlor 12.5%
(Campbell Cleantec, Australia), Maxifoam (Ecolab Pty
Ltd, Australia), Envirosan (Ecolab Pty Ltd, Australia),
Profoam (Jasol Australia, Australia), Kwiksan 22 (Ecolab
Pty Ltd, Australia), acetic acid (Sigma-Aldrich, Mexico),
citric acid (Sigma-Aldrich, Japan), lactic acid (Sigma-Al-
drich, Japan), and propionic acid (Sigma-Aldrich, Japan).
Disinfectants tested in this study are approved for use in
Australian food industries and food processing areas.
Each disinfectant was tested at concentrations spanning
the recommended working concentrations. The active
components of each of the disinfectants are as follows:
Topactive Des.: hydrogen peroxide solution (<10%),
acetic acid (<10%), amines, C12-16- alkyldimethyl
(<10%), N-oxides (<10%), peracetic acid (<10%); Dairy
Chlor: sodium hypochlorite (10- < 30%), sodium hydrox-
ide (<10%); Maxifoam: potassium hydroxide (<10%),
builder (<10%), alkaline salts (<10%), anionic surfactant
(<10%), surfactants (<10%), hydrotrope (<10%), sodium
hypochlorite (<10%) and scale inhibitors (<10%); Enviro-
san: dodecylbenzenesulfonic acid (<10%), propanoic acid,
2-hydroxy-,(s) (<10%); Profoam: quaternary ammonium
compounds (0-5%), surfactants (10-30%); Kwiksan 22:
quaternary ammonium compounds, benzyl-C8-18-alkyl-
dimethyl, chlorides (10- < 30%). Evaluation of the effect-
iveness of the antimicrobial activities of disinfectants
and acids and subsequent determination of the suscepti-
bility profiles were performed on polystyrene microtiter
plate using broth microdilution method as described
previously [36, 37]. Briefly, a single colony from each
isolate was streaked onto TSA agar plates and grown for
18 to 24 h at 37 °C. Working solutions for each disin-
fectant were prepared by diluting with Müller-Hinton
broth (MHB; Oxoid, UK) then sterilising using a
0.45 μm syringe filtre (Sartorius Stedim Biotech GmbH,
Germany). The working solutions were then two-fold
serially diluted to achieve the test concentrations and
pH for each concentration was determined. The disin-
fectant and acid ranges tested were: Topactive DES.
(0.0156%-16%), Dairy Chlor 12.5% (0.0188%-12.5%),
Maxifoam (0.025%-25.6%), Envirosan (0.025%-25.6%),
Profoam: 0.078%-8%, Kwiksan 22 (0.0035%-3.6%), acetic
acid (64-65,536 μg/ml), lactic acid (64-65,536 μg/ml),
citric acid: (64-65,536 μg/ml) and propionic acid (64-
65,536 μg/ml). E. coli O157:H7 Sakai strain was used as
a control for the survival of isolates to disinfectant chal-
lenge and acid challenge assay.
Table 1 PCR Primer sequences used in this study
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Results
Characterization of E. coli O26
A total of 88 isolates were screened for the presence of
PCR gene targets: stx1, stx2, eae, ehx, ecf, bfp and the
rmlA SNP. A summary of the PCR screening and
characterization of clinical and cattle isolates is shown in
Table 2. All of the 88 isolates were found to be negative
for stx2 and bfp. Based on the results of the PCRs four
distinct groupings were formed and subsequently re-
ferred to here as pathotypes: EHEC, potential EHEC
(pEHEC), atypical Enteropathogenic E. coli (aEPEC) and
Non-toxigenic E. coli (NTEC). The EHEC group in-
cludes all human clinical and 40 (51.2%) cattle isolates.
Of the remaining cattle isolates, 33 (42.3%) were aEPEC,
three (3.8%) were pEHEC, and two (2.6%) were NTEC.
Antimicrobial Resistance (AMR)
A total of 88 isolates were assessed for their resistance
to 17 antimicrobials. The distribution of minimum in-
hibitory concentrations (MICs) for each antimicrobial,
concentrations tested and resistance breakpoints are pre-
sented in Table 3. Overall, there was a low level of resist-
ance among the cattle isolates with 86.4% of all isolates
susceptible to all antibiotics tested in this study. In total,
12 (13.6%) E. coli O26 isolates (10 EHEC and two
aEPEC) exhibited resistance to at least one antimicrobial.
Of the 12 isolates, four were resistant to only one anti-
microbial with resistance to streptomycin or nalidixic
acid observed in two and one EHEC isolates from cattle,
respectively, and a single aEPEC isolate from cattle dem-
onstrating resistance to tetracycline. Multidrug resist-
ance was observed in three human clinical and five
cattle isolates. The most common co-resistance pheno-
type observed was ampicillin-kanamycin-streptomycin-
tetracycline (one cattle EHEC isolate and two human
clinical EHEC isolates) and ampicillin-streptomycin
(three cattle EHEC isolates) while resistance to both
chloramphenicol-streptomycin and ampicillin-
streptomycin-tetracycline were found in a human
clinical EHEC isolate and a cattle aEPEC isolate, respect-
ively. Although AMR appeared largely constrained to
EHEC isolates with 20% (10/50) demonstrating resist-
ance to at least one antimicrobial, the differences in
AMR prevalence between pathotypes was found to not
be significant (p = 0.05).
PFGE analysis
Analysis of PFGE patterns revealed that the E. coli O26
strains in this study are highly diverse with similarity be-
tween isolates ranging from 71.4-100% (Fig. 1). Com-
parison of PFGE profiles of 88 isolates identified 75
distinct PFGE patterns at a similarity cut-off level of
100%. At a cut-off value of 90%, isolates could be
grouped into 40 clusters, of which, 19 PFGE clusters
were represented by a single isolate and the remaining
69 isolates grouped into 21 clusters containing between
two and nine isolates. Of the 69 isolates, 44 had distinct
PFGE patterns with the remaining 25 isolates splitting
into 11 clusters of 2 indistinguishable isolates and 1
cluster of 3 indistinguishable isolates. Of note, two iso-
lates that were unrelated temporally (one from cattle
and one from human) produced indistinguishable PFGE
patterns. PFGE patterns were classified into two main
clusters designated A and B at a similarity level of 74%.
Cluster A included 49 (98%) of EHEC, two pEHEC and
one aEPEC isolate. Isolates grouped in cluster B were
97% (32/33) aEPEC as well as two NTEC, a single
pEHEC and a single EHEC isolate. An association
between clusters and AMR isolates were not found (P
value > 0.05). To capture the diversity of E. coli O26
strains, a subset of O26 isolates (n = 40) representing
various AMR profiles, a range of E. coli O26 patho-
types and a diverse PFGE pattern, were then chosen
for subsequent tests.
Susceptibility to disinfectants
The effectiveness of disinfectants currently used in the
food industry against 40 E. coli O26 was examined in
this study and results are shown in Table 4. The pro-
posed industry recommended concentrations for Kwik-
san, Profoam, Topactive DES, Dairy Chlor 12.5%,
Maxifoam and Envirosan were 0.45, 1, 1, 0.3, 1.6, 0.4%,
respectively. The most effective disinfectants with re-
spect to their suggested working concentrations were
Kwiksan 22, Topactive DES and Profoam with each able
to inhibit the growth of the strains tested with MICs at
or below the working concentrations. Dairy Chlor 12.5%,
Maxifoam and Envirosan were less effective against the
40 E. coli O26 examined in this study with all strains
able to grow at a concentration at or above the sug-
gested working concentrations. Importantly, E. coli O26
isolates missing any or all EHEC virulence markers (i.e.,
aEPEC, pEHEC and NTEC) were able to survive the
same concentrations of disinfectant tested in our study
against EHEC isolates, showing the same MICs% as
EHEC. When comparing the effective concentrations of
disinfectants required for E. coli O26 isolates and the
Table 2 Prevalence of genetic markers in E. coli O26 from
clinical and cattle sources
Pathotypes Virulence makers No of isolates Source
EHEC stx (stx1), eae, ehx, ecf,
SNP within rmlA
50 Clinical and cattle
pEHEC eae, ehx, ecf, SNP within
rmlA
3 Cattle
aEPEC eae 33 Cattle
NTEC Negative for all virulence
markers tested
2 Cattle
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control strain E. coli O157:H7 Sakai, similar effectiveness
was observed with elevated MICs demonstrated against
Dairy Chlor 12.5%, (MIC = 2.4%), Maxifoam (MIC =
3.2%) and Envirosan (MIC = 1.6%). The remaining three
disinfectants (Kwiksan 22, Topactive DES. and Profoam)
that have shown to be effective against E. coli O26 were
also effective against E. coli O157:H7 Sakai at the
proposed industry working concentrations.
Susceptibility to acids
The MIC distribution profiles of 40 E. coli O26 isolates
against four acids (acetic, propionic, lactic, and citric
acids) are shown in Table 5. For comparison of MICs of
E. coli O26 to acids with different molecular weights, the
values for molar MICs (MICsmolar) were used. Based on
Weight/Volume (w/v) concentrations it appears that the
order of acids with the most effect on the E. coli O26
strains is acetic acid and propionic then lactic followed
by citric acid with MICs of 1,024, 1024, 2,048, and
4,096 μg/ml, respectively (Table 5). Recalculation of the
MICs to molar values reveals that propionic, acetic, cit-
ric and lactic acids have MICsmolar of 13.82, 17.05, 21.3
and 22.7 mmole/ml, respectively, suggesting that propio-
nic acid shows higher efficacy than acetic acid at retard-
ing the growth of E. coli O26. When exposed to acids,
the MICs for all 40 isolates occurred at an acetic acid
pH and propionic acid pH that was much less acidic
than that of the other two acids. The MICsmolar for
87.5% (35/40) and 12.5% (5/40) of isolates occurred at
an acetic acid pH 4.08 and 4.42, respectively. For propio-
nic acid the MICsmolar for 100% (40/40) of isolates
occurred at pH of 4.55. When exposed to citric acid, the
MICsmolar for 87.5% (35/40) and 12.5% (5/40) of isolates
were observed at citric acid pH of 3.75 and 3.31, respect-
ively, whereas the MICsmolar for 100% (40/40) of the iso-
lates occurred at lactic acid pH of 3.67. No significant
differences in susceptibility to acids was observed be-
tween pathotypes regardless of the type of acid assessed.
Of note, the MICs of the tested E. coli O26 isolates in
the acid challenge assay were comparable to the MIC
values observed for the control strain of E. coli O157:H7
Sakai with MICs for acetic, citric, propionic and lactic
acids of 512, 2048, 1024 and 2048 μg/mL observed.
Discussion
O26 is the second most prevalent serotype identified in
cases of foodborne illness attributed to E. coli in
Australia and throughout the world. A range of mea-
sures exist for food producers to limit the spread and
transfer of these organisms, however little is known
about the variability of response to these control mea-
sures by E. coli O26 isolates. Isolates included in this
study could be categorised into four pathotypes (EHEC,
pEHEC, aEPEC and NTEC) based on the presence or
absence of EHEC associated markers (stx, eae, ehx).
Whilst isolates belonging to the EHEC group are of most
Table 3 Distribution of antimicrobial MICs among E. coli O26 isolates from cattle and human sources
aOnly a susceptible breakpoint (≤4 μg/ml) has been established. Isolates with an MIC ≥8 μg/ml are reported as non-susceptible. Vertical lines indicate breakpoints
for resistance. The white fields indicate the dilution range tested for each antimicrobial. Grey area indicates MIC values greater than or less than the tested
concentration. Number of isolates is in percentage (%).*CI: Confidence intervals
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Fig. 1 (See legend on next page.)
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interest because of their link to human clinical disease,
this study identified a number of pEHEC organisms that
appear to differ from EHEC isolates through the absence
of stx. The ability of EHEC to acquire and lose stx has
been described previously [38] and consequently there
is a need to consider the clinical impact of these
isolates.
The development of antimicrobial resistance within E.
coli and particularly EHEC O26 remains an ongoing
concern. In this study, a low level of antimicrobial resist-
ance was observed with 86.4% of isolates susceptible to
all antimicrobials tested. These data are consistent with
other studies that evaluated the AMR status of E. coli in
Australian cattle populations at slaughter and in food
purchased at retail [39, 40]. These studies determined
that approximately >92% of isolates were susceptible to
all antimicrobials tested. Furthermore, resistance to anti-
microbials of critical or high importance in human
medicine was not identified. As previously stated, com-
parison of the AMR results from different E. coli O26
pathotypes determined that although resistance was
largely identified in EHEC isolates, these differences
were not significant from any of the other pathotypes.
The use of PFGE enabled the identification of two dis-
tinct clusters at a similarity level of 75%. Cluster A was
primarily composed of EHEC isolates and included a
large proportion (98.7%) of isolates that were positive for
the ecf and SNP within rmlA suggesting that these
markers are notable features that could be used to define
cluster A from cluster B. Interestingly, an individual
aEPEC isolate grouped in PFGE cluster A and one EHEC
isolate grouped into cluster B where the majority of iso-
lates were aEPEC. This result may reinforce the hypoth-
esis of emergence of EHEC and Non-EHEC by loss and
gain of the stx gene. In fact, previous studies showed
that conversion of EHEC O26 to stx-negative E. coli O26
is bidirectional where EHEC O26 lose stx genes convert-
ing to aEPEC and aEPEC O26 can be lysogenised with
Stx-encoding phages to give rise to the emergence of
EHEC [38]. Another explanation could be that aEPEC
isolates located in the same cluster with EHEC may
contain pathogenic O island (OI-122, OI-43. OI-48,
OI-50 or OI-57) encoded genes which were found to
be significantly associated with aEPEC that showed
high similarity to EHEC irrespective of their virulence
attributes [41, 42].
E. coli O26 strains that have been responsible for a
number of foodborne outbreaks or isolated from a var-
iety of food matrices and food producing animals draw
attention to their tolerance to the environmental stresses
applied in the food processing areas and food industry
[19, 21, 25, 43]. Subsequently, an evaluation for the ef-
fectiveness of the sanitizers used in the food processing
environment, and food contact surfaces is crucial for un-
derstanding effective pathogen control. Both Profoam
and Kwiksan are Quaternary Ammonium Compound
(QACs) cationic surfactants that are widely used in clin-
ical and industrial settings. Similarly, Topactive DES.
which has peracetic acid as its active ingredient is used
in the food industry and for disinfection of medical
supplies. The observed MICs of E. coli O26 of different
pathotypes to a range of QACs (Profoam and Kwiksan)
and Topactive DES demonstrated that the required
MICs for inhibiting the growth of E. coli O26 carrying
EHEC virulence markers (EHEC) and pathotypes lacking
EHEC virulence factors (aEPEC, pEHEC and NTEC) are
similar to that for E. coli O157 Sakai strain used as a
control in our study. This suggests that the
(See figure on previous page.)
Fig. 1 PFGE profiles and clusters of O26 isolates investigated in this study. All 88 isolates were analysed by PFGE with XbaI, and cluster analysis of
the patterns was performed by BioNumerics V7.5 software using the Dice coefficient and unweighted pair group method (UPGMA). The degree
of similarity (%) is shown on the scale at the top left of the figure. The cut-off level of 90% was chosen to assign isolates to the same cluster. At
74% similarity isolates were assigned to 2 clusters (a & b)
Table 4 Distribution of disinfectant MICs among 40 E. coli O26 isolates from cattle and human sources
Light Grey fields indicate the recommended working concentrations for each disinfectant, Dark Grey fields indicate the dilution range tested for each disinfectant
agents. Numbers in the white field indicates number and percentage of isolates susceptible to disinfectants at the tested concentration
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manufacturers’ recommended concentrations for the
tested disinfectants validated for O157 strain are effect-
ive for the control of E. coli O26 of various pathotypes
and are may indeed be effective for most E. coli regard-
less of pathotypes or serogroup.
When challenged for their capability to survive disinfec-
tants with sodium hypochlorite as the main component,
both human and cattle E. coli O26 isolates of different
pathotypes achieved MICs that exceeded the application
concentrations. Consequently all forty isolates regardless of
their pathotype were deemed to be non-susceptible to the
recommended concentrations of Maxifoam and Dairy
Chlor 12.5%. Pathogens that survive recommended concen-
trations of tested disinfectants pose a greater risk of spread-
ing into the food supply chain and subsequently could
contribute to the incidence of human disease thereby re-
inforcing the importance of continued evaluation of disin-
fectants. Škaloud et al.,[31] reported that the MIC of
sodium hypochlorite for both STEC O157 and O26 was
0.5% which is lower than the effective concentrations for
disinfection of E. coli O26 in this study. Although these
data may suggest variations among E. coli strains in
response to disinfectant stress comparison of the current
results with others is difficult since the chosen susceptibility
method is different. Previous studies raised concerns about
the use of disinfectants and developing resistance to anti-
microbial agents [32, 36, 44]. These studies suggested that
the use of disinfectants may impose selective pressure giv-
ing rise to the emergence of cross-resistance and co-
resistance for widely used disinfectants and antimicrobial
agents. In our study, the percentage of resistance to a range
of disinfectants was similar among O26 isolates regardless
of their AMR status and no association between the use of
disinfectants and development of resistance to antimicro-
bial agents was found suggesting that the presence of either
resistance has not resulted in selection for the other.
Organic acids have been used in foods as preservatives
to enhance microbial safety. In addition, acids may be
used as interventions in the beef industry to reduce bac-
terial contamination. Results presented here show that
the majority of isolates (87%), regardless of their source
and pathotypes, exhibited elevated MICs (≥1024 μg/ml)
to the tested acids. A previous study on the influence of
organic acids on E. coli O157:H7 demonstrated elevated
MICs for those acids as well [32]. In addition, the MICs
for the E. coli O26 isolates in this study occurred at low
pH (4.55-3.31). Molina et al., [45] have shown that STEC
O26 and other STEC serotypes (O91:H2, O111:H-,
O145: H-, and O157:H7) did not grow when they were
exposed to citric acid and acetic acid at a pH of 4.5.
Others reported that treatment with lactic acid at a con-
centration of 4%, reduced non-O157 including E. coli
O26 by 2.3 log [30]. Findings from the current and pre-
vious studies suggest that E. coli O26 isolates of different
pathotypes utilize a number of acid resistance mecha-
nisms to prevent the lethal effect of acidic stresses. The
capacity of E. coli strains to withstand acidic environ-
ments during passage and growth of these bacteria in
the intestinal tracts of cattle and human and in acidic
food is an important factor that influence their ability to
survive and subsequently cause disease [46].
Conclusion
In conclusion, E. coli O26 isolated in Australia are a gen-
etically diverse group of organisms that belong to a
range of pathotypes. The low level of resistance and the
absence of AMR to clinically relevant antimicrobials in
Australian cattle bacterial isolates are reflective of the
comprehensive controls over the use of antimicrobials in
food-production animals in Australia. However, the tol-
erance of EHEC and stx-negative E. coli O26 pathotypes
(i.e., aEPEC, pEHEC and NTEC) to three of the tested
disinfectants (Maxifoam, Dairy Chlor 12.5% and Enviro-
san) and the elevated MICsμg/ml to the acids examined
in this study might contribute to bacterial colonisation
of food contact surfaces, which may result in product
contamination and subsequently foodborne illness. The
ability of E. coli O26 isolates to survive a stress interven-
tion was not related to a specific pathotype as isolates
lacking EHEC associated markers such as stx or eae per-
sisted at the same proportion as EHEC strains suggest-
ing that other factors affect persistence of E. coli O26
strains. Knowledge of the virulence factors and genetic
relatedness of E. coli O26 may improve our
understanding of the capability of E. coli O26 to survive
stress and subsequently cause human illness. Continuous
evaluation of disinfectants and acids for their efficacy in
reducing E. coli O26 should be conducted by food
industries to assist in ensuring E. coli O26 is limited in
its capacity to persist in food processing environments
and contribute to foodborne disease.
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